Entomologists review pros, cons and regulatory issues surrounding new technology that could help halt the spread of diseases such as Zika virus, dengue fever and malaria
Engineered gene drives, which have the potential to spread desirable genes throughout wild populations or to suppress harmful species, have received a lot of recent attention because of their potential to control organisms, such as mosquitoes that carry diseases such as Zika virus, malaria and dengue fever.
At the same time, the recently discovered CRISPR gene editing technology has the potential to create, streamline and improve the development of gene drives.
In a highly innovative and technical review, an entomologist at the University of California, Riverside has examined the different gene drives systems, analyzed the pros and cons of each and applications associated with them, and also surveyed the safety and regulatory issues associated with them.
“Despite all the potential benefits of gene drives, they remain understudied,” said Omar Akbari, an assistant professor of entomology at UC Riverside. “With that in mind, and with advances occurring so quickly, we wanted to step back and take a broad look at what is happening.”
Akbari, who is also a member of UC Riverside’s Center for Disease Vector Research andInstitute for Integrative Genome Biology, is the corresponding author of the piece, “Cheating evolution: engineering gene drives to manipulate the fate of wild populations,” that was just published online in the journal Nature Reviews Genetics. The piece was co-authored by Jackson Champer and Anna Buchman, both post-doctoral students working with Akbari.
The idea of editing the genes of organisms to address biological problems related to public and environmental health has been around for decades. In fact, the authors cite a paper from 1940 and others from the late 1960s that discuss this.
Despite the wide-ranging applicability and importance of gene drives, there has been only modest development in their progress in past decades. Gene drives capable of functioning in wild populations have been created in only a few organisms, including yeast, the fruitfly and two species of mosquitoes.
This is, in part, due to the difficulty of engineering the genomes of organisms. However, recent advancements have provided tools capable of engineering the genomes of diverse species. The most promising of these tools is CRISPR.
Combining gene drives and a tool such as CRISPR may enable the development of novel strategies to reduce or eliminate insect-borne diseases, remove invasive foreign species, and even reverse the development of resistance to insecticides and herbicides, in an economically viable and environmentally friendly manner.
In the paper, the authors focus on several types of gene drives, including homing-based drives, sex-linked meiotic drives, medea and underdominance gene drives. They describe the gene drives based on different attributes, including rate of spread, species specificity, fitness cost, susceptibility to resistance,removability and reversibility.
They also discuss whether the gene drives are classified as ‘modification drive’ types, which are designed to spread through a population carrying desirable traits, or as ‘suppression drive’ types, which have the effect of reducing the population of a target species.
Finally, the authors address safety and regulation. They mention dangers associated with gene drives, including the potential to cause extinctions, to spread outside a geographical area or traverse into another species and the potential misuse to cause economic damage or even bioterrorism.
Learn more: Engineered Gene Drives and the Future
The Latest on: Engineered gene drives
via Google News
The Latest on: Engineered gene drives
- Who is afraid of genetically modified mosquitoes?on June 24, 2020 at 7:14 pm
Greg Odogwu Genetically Modified Organisms have raised concerns in our clime, the same way they have in other countries of the world – where a clear line is drawn between the pro and the anti-GMO ...
- 2016: As The Hardware World Turnson June 17, 2020 at 5:00 pm
Since the dawn of computing, we have all wanted one port. We needed something to attach microphones, hard drives, keyboards, printers, and phones to our computers. It would be nice if this port ...
- Gene Therapy for Rheumatoid Arthritison June 16, 2020 at 5:00 pm
Restoration of the balance between proinflammatory and immunosuppressant cytokines through gene therapy can effectively attenuate arthritis. Apoptosis induction and the inhibition of angiogenesis ...
- Are Genetically Engineered Mice The Answer To Combating Lyme Disease?on June 16, 2020 at 12:49 am
So, if mice could be engineered to be resistant to tick-borne ... unworkable unless one of the controversial methods of gene drive were used, involving foreign non-mouse DNA.
- Gene Engineered Subunit Vaccine Market Analysis, Trends and CAGR Projections 2020-2026on June 12, 2020 at 10:58 am
A recent report provides crucial insights along with application based and forecast information in the Global Gene Engineered Subunit Vaccine Market. The report provides a comprehensive analysis of ...
- When Profits and Politics Drive Science: The Hazards of Rushing a Coronavirus Vaccine at “Warp Speed”on June 11, 2020 at 3:30 pm
over 1,200 emails released under open records requests revealed that the US military is now the top funder behind the controversial “genetic extinction” technology known as “gene drives.” ...
- Regenerative Medicine Gets Weavingon June 5, 2020 at 12:05 am
To mass produce recombinant human collagen (rhCollagen), CollPlant Biotechnologies uses tobacco plants, genetically engineered with the five genes responsible ... that will drive new breakthroughs ...
- Tumour metabolites hinder DNA repairon June 3, 2020 at 8:03 am
Mutations targeting the genes encoding the enzymes isocitrate ... both the recruitment of repair factors and DSB repair at an engineered DNA-damage site, compared with the effects seen in cells ...
- Replimune Reports Fiscal Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updateon June 3, 2020 at 5:40 am
June 03, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (REPL), a biotechnology company developing a series of oncolytic immuno-gene therapies ... continues to drive deep and durable responses ...
- The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cellson June 1, 2020 at 5:00 pm
Correspondingly, the expression of interferon (IFN)–responsive genes (IRGs) in cells and in mice was positively ... inhibition of IRAK4 reduced the expression of IRGs during disease onset. Mice ...
via Bing News